Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. | Neuropharmacology;39(10): 1913-9, 2000 Jul 24. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression.

Parker, E M; Monopoli, A; Ongini, E; Lozza, G; Babij, C M.

Affiliation

Parker EM; Department of CNS and Cardiovascular Research, Mail Stop K-15-3-3600, Schering-Plough Research Institute, 2015 Galloping Hill Road, NJ 07033, Kenilworth, USA. eric.parker@spcorp.com

Neuropharmacology ; 39(10): 1913-9, 2000 Jul 24.

Article in En | MEDLINE | ID: mdl-10884572

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Cell Cycle / Neurites / Tacrolimus / Sirolimus Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neuropharmacology Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Cell Cycle / Neurites / Tacrolimus / Sirolimus Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neuropharmacology Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido